Activation of NR1H3 signaling pathways by psoralidin attenuates septic myocardial injury

Yang Yang,Wangrui Lei,Lu Qian,Shaofei Zhang,Wenwen Yang,Chenxi Lu,Yanbin Song,Zhenxing Liang,Chao Deng,Ying Chen,Ye Tian,Huadong Zhao
DOI: https://doi.org/10.1016/j.freeradbiomed.2023.04.006
IF: 8.101
2023-04-22
Free Radical Biology and Medicine
Abstract:Sepsis can cause various organ dysfunction, which heart failure may be associated with significant mortality. Psoralidin (PSO), one of the main bioactive compounds from the seeds of Psoralea corylifolia L, exhibits remarkable protective effects in diseases, including cancer, osteoporosis, and depression. Recently, NR1H3 is one of the emerging nuclear receptors targets for the various drugs. This study first reported the role of PSO in septic myocardial injury, which was mainly attributed to the NR1H3-dependent manner. NR1H3 knockout mice subjected to cecal ligation and puncture (CLP) were used to investigate the involvement of NR1H3 in PSO protection evaluate. Our results showed that PSO prominently improved cardiac function, blood routine and blood biochemistry, attenuated inflammation, inhibited oxidative stress, improved mitochondrial function, regulated ERS, suppressed apoptosis, and increased NR1H3 and p-AMPK levels. However, NR1H3 knockout reversed the positive role of PSO in septic mice. Furthermore, activation of NR1H3 by T0901317 also increased the activity of AMPK and ACC in the HL-1 cardiomyocytes, indicating the regulatory relationship between NR1H3 and AMPK signaling. This study first demonstrated the beneficial effect of PSO in septic myocardial injury through activation of NR1H3/AMPK pathway.
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?